Envoy Medical

02/25/2026

🌎Celebrating International Cochlear Implant Day!

Cochlear implants are an important option for people with more significant hearing loss who may not receive enough benefit from traditional hearing aids. Unlike hearing aids, which amplify sound acoustically, cochlear implants work by bypassing the damaged areas of the inner ear and delivering sound information through electrical stimulation of the auditory nerve.

Today, we join the global community in raising awareness of cochlear implant technology, ongoing research, and the many individuals and organizations who advance the field.

As our own fully implanted cochlear implant system remains investigational and is currently being studied in U.S FDA clinical trials, we are proud to support awareness efforts and contribute to continued innovation in hearing health.

Please join us in spreading awareness on February 25 by using the hashtag .

CAUTION: Investigational device. Limited by federal (or United States) law to investigational use.

02/25/2026

ICYMI! We hope you can join us this morning!

We invite you to join Envoy Medical for a Fireside Chat on Wednesday, February 25, 2026, at 10:00 a.m. ET.

Brent Lucas, Envoy Medical’s CEO, will host a discussion with Dr. Theodore McRackan, a Principal Investigator in the Acclaim® pivotal clinical trial and a cochlear implant surgeon at the Medical University of South Carolina.

Dr. McRackan has implanted 14 of the 47 subjects enrolled to date—the first site in this pivotal clinical trial to reach this milestone. During the conversation, he will share early impressions, insights, and the potential impact of Envoy Medical’s fully implanted technology pending future regulatory submission and approval.

Event: Envoy Medical Fireside Chat
Date: Wednesday, February 25, 2026
Time: 10:00 a.m. ET
Register: https://hubs.li/Q044Cq180

We look forward to having you join us.
CAUTION: Investigational device. Limited by federal (or United States) law to investigational use.

02/24/2026

We’re excited to share an important update from Envoy Medical!

Nasdaq has formally confirmed that Envoy Medical (NASDAQ: COCH) is back in compliance with its continued listing requirements. Thanks to our recent strategic financing efforts and a stronger balance sheet, we are pleased to continue trading on the Nasdaq Capital Market under the symbol COCH.

This milestone supports the continued momentum of our work to bring forward fully implanted hearing technologies like the Esteem® FI‑AMEI and the investigational Acclaim® Cochlear Implant.

Learn more here: https://hubs.li/Q044rNNp0

CAUTION. The fully implanted Acclaim Cochlear Implant is an investigational device. Limited by Federal (or United States) law to investigational use.

Envoy Medical regains Nasdaq compliance through strategic financing, ensuring continued innovation in fully implanted hearing solutions. Learn more about their groundbreaking technologies and future plans.

02/23/2026

We’ve secured three new patents — one in the United States and two in Hong Kong — helping us continue our work in the future of fully implanted hearing technology.

At Envoy Medical, we’re developing a different approach to hearing solutions. Our Nature’s Microphone™ technology is designed to use the natural ear to capture sound, rather than relying on external microphones or devices worn on or in the ear. Many people with hearing loss rely on devices that need to be put on, removed, or managed throughout the day — which can mean there are moments when they’re not connected to sound. We’re working on a path that could one day help change that.

This different approach is present in our investigational Acclaim® Cochlear Implant, which is currently being evaluated in a U.S. pivotal clinical trial. Our goal is to advance technology that prioritizes access, ease of use, and long‑term usability and these patents further support that goal.

We’re grateful to everyone who supports Envoy Medical — including the hearing loss community and the families who walk alongside them. Your encouragement keeps us moving forward as we work to push hearing technology beyond the status quo.

Learn more here: https://hubs.li/Q044dT3p0


CAUTION: The fully implanted Acclaim Cochlear Implant is an investigational device. Limited by Federal (or United States) law to investigational use.

Envoy Medical secures three new patents, reinforcing its competitive edge in fully implanted hearing solutions and paving the way for future innovations in the cochlear implant industry.

02/19/2026

Progress Toward a New Fully Implanted Option for Hearing Loss

Envoy Medical is making important progress in our pivotal clinical trial for the investigational fully implanted Acclaim® Cochlear Implant. Forty‑seven people have already been implanted, and the remaining participants are scheduled for surgery. Once enrollment is complete, each participant will be followed for one year. The next major step is gathering and analyzing that data as we move toward the regulatory submission and review process.

We also recently secured new financing that helps us continue advancing this work.

On February 25 at 10 a.m. ET, Envoy Medical’s CEO will host a Fireside Chat with Dr. Theodore McRackan, a surgeon who has implanted the Acclaim® cochlear implant in 14 trial participants. They will discuss early insights and the potential impact of this technology if it is approved.

Link to press release:https://hubs.li/Q043SHJS0

Register here: https://hubs.li/Q043SJdw0

CAUTION: The fully implanted Acclaim Cochlear Implant is an investigational device. Limited by Federal (or United States) law to investigational use.

Envoy Medical secures $78M in financing, advancing their investigational and innovative cochlear implant technology towards commercialization with promising clinical trial progress and insights from Dr. Theodore McRackan.

02/17/2026

We’ve been busy at Envoy Medical — and the momentum is strong!

We’re excited to share that 45 of 56 participants have now been implanted with our investigational fully implanted Acclaim® cochlear implant in the pivotal clinical trial, putting it at over 80% enrolled. Full enrollment is anticipated by the end of March.

"Reaching 45 implanted patients and being approximately one month away from full enrollment is an exciting milestone for our entire organization. The journey to get to this point has been long, but we are now moving quickly and with great confidence." — Brent Lucas, CEO

The Acclaim® implant is designed to leverage the ear to capture sound with no external components worn on or in the ear – similar to the way nature intended.

Learn more here:https://hubs.li/Q043nKHn0

CAUTION: The fully implanted Acclaim Cochlear Implant is an investigational device. Limited by Federal (or United States) law to investigational use.

02/12/2026

Envoy Medical Announces Closing of Upsized Public Offering

We’re excited to share that we’ve closed an upsized public offering with $30M upfront and up to $48M of potential aggregate gross proceeds upon exercise in full of milestone‑linked warrants for cash.

The raise was led by top-tier healthcare fund Nantahala Capital with strong support from other well-established healthcare funds and investors. Existing shareholders including long-time supporter Glen Taylor and members of our Board and management team also participated in a meaningful way.

This funding extends our cash runway into the second half of 2027, beyond our expected PMA submission. If the milestones are met and warrants are exercised in full, the funding could potentially take us through the first year or two of commercialization (if FDA approval is achieved).

A huge thank you to our new and existing investors for their confidence in our mission to bring our breakthrough fully implanted cochlear implant to market.

Learn more here:

$30.0 million upfront with up to an additional $48.0 million of potential aggregate gross proceeds upon the exercise in full of…...

02/11/2026

Envoy Medical Announces Pricing of Upsized Public Offering

Today we announced the pricing of an upsized public offering, raising $30 million gross upfront (minus fees and expenses) with the potential for up to $48 million in gross proceeds from additional milestone‑linked warrant proceeds. These funds will support our operations and our ongoing FDA pivotal study for the investigational Acclaim® fully implanted cochlear implant, which previously received FDA Breakthrough Device Designation.

We remain committed to advancing fully implanted hearing solutions for people across the hearing loss spectrum.

Learn more here: https://hubs.li/Q042Hc3-0



CAUTION. The fully implanted Acclaim Cochlear Implant is an investigational device. Limited by Federal (or United States) law to investigational use.

02/10/2026

February is a time to reconnect. ♥️❤️❤️

Whether it’s a parent, partner, friend, or teen — these real conversation tips help everyone feel included when hearing loss is in the mix.

Catch this month’s Sounding Board: Hearing Loss and the Art of Staying Connected.
Here: https://hubs.li/Q042yvFw0

02/06/2026

February is Low Vision Awareness Month, a reminder that accessibility isn't optional, it's essential.
For people living with hearing loss and low vision, managing tiny devices, batteries, and daily adjustments can be exhausting or impossible. That's why ease of use matters.

An Invisible Hearing® experience reduces visual and physical demands, helping people stay independent and engaged without daily device management.

Accessibility matters. Independence matters. Dignity matters.

Learn more here: https://hubs.li/Q0428nP00

01/27/2026

🌡️❄️ DID YOU KNOW?

Extreme cold can affect all kinds of external hearing devices — hearing aids, earbuds, and mainstream headphones. Below‑zero temps can cause battery drain, condensation when moving between indoors and outdoors, and even stiff or sluggish components, which may lead to temporary distortion or reduced performance.

This isn’t device failure — it’s just physics.
Winter tips:
✔ Keep devices warm under a hat or ear warmer
✔ Store spare batteries in a pocket
✔ Use a drying box or dehumidifier overnight
✔ Avoid leaving devices in cold cars or garages

At Envoy Medical, our fully implanted technology is designed to stay protected inside the body, but we’re committed to supporting everyone in the hearing‑loss community—no matter what devices they use. Stay warm, stay safe, and protect your hearing this winter. 💙❄️

01/23/2026

New Year, New Progress in Hearing Health!

New research and emerging technologies are expanding possibilities for people with hearing loss.

Explore what's on the horizon this month’s Sounding Board article, "What’s Coming Next in Hearing Health."

Read it here: https://hubs.li/Q0400c0V0